Thyroid cancer in patients undergoing thyroidectomy total in the Otorhinolaryngology Department of the Hospital de Clínicas during the period 2018-2022

Ricardo Serrano; Carlos Mena-Canata; Raúl Tornaco-Maidana; Marcelo Villalba

doi:10.52379/mcs.v8i2.398

Authors

Ricardo Serrano , Universidad Nacional de Asunción, Facultad de Ciencias Médicas, San Lorenzo, Paraguay
Carlos Mena-Canata , Universidad Nacional de Asunción, Facultad de Ciencias Médicas, San Lorenzo, Paraguay https://orcid.org/0000-0003-4429-4840
Raúl Tornaco-Maidana , Universidad Nacional de Asunción, Facultad de Ciencias Médicas, San Lorenzo, Paraguay https://orcid.org/0000-0003-2291-8106
Marcelo Villalba , Universidad Nacional de Asunción, Facultad de Ciencias Médicas, San Lorenzo, Paraguay https://orcid.org/0009-0007-6842-7704

Keywords:

Array, Array, Array, Array

Abstract

Introduction: Thyroid cancer, considered one of the most frequent malignant tumors of the endocrine system, accounts for 80%–90% of cases. The most common histological type observed in most studies is papillary cancer. Objective: To determine the frequency of thyroid cancer in patients undergoing total thyroidectomy at the Otorhinolaryngology Department of the Hospital de Clínicas between the period 2018-2022. Methodology: This retrospective study included 260 patients treated during the study period. Data were obtained from the patients' medical records, and sociodemographic and clinical variables related to thyroid cancer were analyzed. Data were analyzed with the SPSS v25 program, using descriptive statistics. Results: The frequency of thyroid cancer was 48.1%. The mean age of the cancer patients was 42.10±13.10 years. A higher frequency was observed in females 34.2%, n=89) and among those aged 25-44 years 20.0%, n=52). The most frequent were papillary (36.9%), follicular (2.7%), medullary (1.5%), and anaplastic (1.2%) types. Discussion: The frequency of thyroid cancer is high; it is more common in women and as age increases.

Downloads

Download data is not yet available.

References

Busco S, Giorgi Rossi P, Sperduti I, Pezzotti P, Buzzoni C, Pannozzo F. Increased incidence of thyroid cancer in Latina, Italy: A possible role of detection of subclinical disease. Cancer Epidemiol. 2013;37(3):262-9. https://doi.org/10.1016/j.canep.2013.02.007

National Cancer Institute. SEER. 2020. Citado 21 de noviembre de 2023. SEER Cancer Statistics Review, 1975-2016. URL

Dal Maso L, Panato C, Franceschi S, Serraino D, Buzzoni C, Busco S, et al. The impact of overdiagnosis on thyroid cancer epidemic in Italy,1998–2012. Eur J Cancer. 2018;94:6-15. https://doi.org/10.1016/j.ejca.2018.01.083

Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C, et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 2022;10(4):264-72. https://doi.org/10.1016/s2213-8587(22)00035-3

Schonfeld SJ, Lee C, Berrington de González A. Medical exposure to radiation and thyroid cancer. Clin Oncol R Coll Radiol G B. 2011;23(4):244-50. https://doi.org/10.1016/j.clon.2011.01.159

Wolin KY, Carson K, Colditz GA. Obesity and cancer. The Oncologist. 2010;15(6):556-65. https://doi.org/10.1634/theoncologist.2009-0285

Estrada AP, Bohórquez ME, Prieto R, Duque CS, Vélez A, Mateus G, et al. Asociación de factores ambientales con el carcinoma de tiroides en pacientes colombianos. Rev Colomb Cancerol. 2017;21(1):46. http://dx.doi.org/10.1016/j.rccan.2017.02.007

Mondragón-Terán P, López-Hernández LB, Gutiérrez-Salinas J, Suárez-Cuenca JA, Luna-Ceballos RI, Erazo Valle-Solís A. Mecanismos de señalización intracelular en cáncer de tiroides. Cir Cir. 2016;84(5):434-43. https://doi.org/10.1016/j.circir.2016.05.017

Schmidt A, Cross G, Pitoia F. Metástasis a distancia en cáncer diferenciado de tiroides: diagnóstico y tratamiento. Rev Argent Endocrinol Metab. 2017;54(2):92-100. https://doi.org/10.1016/j.raem.2017.05.001

Lanitis S, Gkanis V, Sekadakis D, Lainas S, Ntalaperas K, Tournis S, et al. High rate of Incidental thyroid Cancer in Greece. Is it a time to revise the literature? Eur J Surg Oncol. 2023;49(2):e146-7. https://doi.org/10.1016/j.ejso.2022.11.412

Leboulleux S, Tuttle RM, Pacini F, Schlumberger M. Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? Lancet Diabetes Endocrinol. 2016;4(11):933-42. https://doi.org/10.1016/s2213-8587(16)30180-2

Galofré JC. Incidencia de cáncer de tiroides: el descubrimiento del iceberg oculto. Endocrinol Diabetes Nutr. 2017;64(6):285-7. https://doi.org/10.1016/j.endinu.2017.04.001

Palmero CS, López MM, Zelaya SP, Díaz LM, Morresi LE, Muñoa E, et al. Incidencia de cáncer de tiroides en la provincia de Río Negro. Rev Argent Endocrinol Metab. 2016;53(1):16-21. https://doi.org/10.1016/j.raem.2016.05.004

Díaz-Soto G, Torres Torres B, López JJ, García S, Álvarez Quiñones M, de Luis D. Incidencia y estadificación dinámica del riesgo del carcinoma diferenciado de tiroides en una unidad de alta resolución. periodo 2002-2017. Endocrinol Diabetes Nutr. 2021;68(9):636-41. https://doi.org/10.1016/j.endinu.2020.10.014

Cohen Sabban MA, Palmero C, Bertrand B, Aiello A, Ghiglioni A, Mac Donell MC, et al. Incidencia de cáncer de tiroides en la provincia de Neuquén, período 2001-2012. Endocrinol Nutr. 2014;61(9):455-9. https://doi.org/10.1016/j.endonu.2014.04.005

Araque DVP, Bleyer A, Brito JP. Thyroid cancer in adolescents and young adults. Future Oncol Lond Engl. 2017;13(14):1253-61. https://doi.org/10.2217/fon-2017-0024

Dal Maso L, Lise M, Zambon P, Falcini F, Crocetti E, Serraino D, et al. Incidence of thyroid cancer in Italy, 1991–2005: time trends and age–period–cohort effects. Ann Oncol. 2011;22(4):957-63. https://doi.org/10.1093/annonc/mdq467

Leenhardt L, Grosclaude P. Épidémiologie des cancers thyroïdiens dans le monde. Ann Endocrinol. 2011;72(2):136-48. https://doi.org/10.1016/j.ando.2011.03.025

Haymart MR, Banerjee M, Reyes-Gastelum D, Caoili E, Norton EC. Thyroid Ultrasound and the Increase in Diagnosis of Low-Risk Thyroid Cancer. J Clin Endocrinol Metab 2019;104(3):785–792. https://doi.org/10.1210/jc.2018-01933

Davies L. How Understanding Thyroid Cancer in Belgium Can Help Us Mitigate the Problem of Increasing Incidence. J Clin Endocrinol Metab. 2013;98(10):3977-9. https://doi.org/10.1210/jc.2013-3505

Genere N, El Kawkgi OM, Giblon RE, Vaccarella S, Morris JC, Hay ID, et al. Incidence of Clinically Relevant Thyroid Cancers Remains Stable for Almost a Century: A Population-Based Study. Mayo Clin Proc. 2021;96(11):2823-30. https://doi.org/10.1016/j.mayocp.2021.04.028

Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013. JAMA. 2017;317(13): 1338-1348. https://doi.org/10.1001/jama.2017.2719

Janz TA, Neskey DM, Nguyen SA, Lentsch EJ. Is the incidence of anaplastic thyroid cancer increasing: A population based epidemiology study. World J Otorhinolaryngol - Head Neck Surg. 2019;5(1):34-40. https://doi.org/10.1016/j.wjorl.2018.05.006

Fernández-Vañes L, Llorente JL, García-Cabo P, Menéndez M, Pedregal D, Rodrigo JP, et al. Manejo de los carcinomas diferenciados de tiroides. Acta Otorrinolaringológica Esp. 2019;70(4):200-6. https://doi.org/10.1016/j.otorri.2018.03.002